D. Maloney, Anti-CD20 Antibody Therapy for B-Cell Lymphomas, New England Journal of Medicine, vol.366, issue.21, pp.2008-2016, 2012.
DOI : 10.1056/NEJMct1114348

A. Chan and P. Carter, Therapeutic antibodies for autoimmunity and inflammation, Nature Reviews Immunology, vol.10, issue.5, pp.301-316, 2010.
DOI : 10.1038/nri2761

L. Weiner, R. Surana, and S. Wang, Monoclonal antibodies: versatile platforms for cancer immunotherapy, Nature Reviews Immunology, vol.279, issue.5, pp.317-327, 2010.
DOI : 10.1038/nri2744

R. Clynes, T. Towers, L. Presta, and J. Ravetch, Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets, Nat Med, vol.6, issue.4, pp.443-446, 2000.

J. Uchida, The Innate Mononuclear Phagocyte Network Depletes B Lymphocytes through Fc Receptor???dependent Mechanisms during Anti-CD20 Antibody Immunotherapy, The Journal of Experimental Medicine, vol.16, issue.12, pp.1659-1669, 2004.
DOI : 10.1016/S0022-1759(00)00346-X

G. Cartron, Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor Fcgamma RIIIa gene, Blood, vol.99, issue.3, pp.754-758, 2002.
DOI : 10.1182/blood.V99.3.754

M. Biburger, Monocyte Subsets Responsible for Immunoglobulin G-Dependent Effector Functions In??Vivo, Immunity, vol.35, issue.6, pp.932-944, 2011.
DOI : 10.1016/j.immuni.2011.11.009

URL : http://doi.org/10.1016/j.immuni.2011.11.009

P. Boross and J. Leusen, Mechanisms of action of CD20 antibodies, Am J Cancer Res, vol.2, issue.6, pp.676-690, 2012.

G. Sarikonda, Transient B-Cell Depletion with Anti-CD20 in Combination with Proinsulin DNA Vaccine or Oral Insulin: Immunologic Effects and Efficacy in NOD Mice, PLoS ONE, vol.107, issue.2, p.54712, 2013.
DOI : 10.1371/journal.pone.0054712.s002

J. Cyster and C. Goodnow, Pertussis toxin inhibits migration of B and T lymphocytes into splenic white pulp cords, Journal of Experimental Medicine, vol.182, issue.2, pp.581-586, 1995.
DOI : 10.1084/jem.182.2.581

L. Ganesan, FcgammaRIIb on liver sinusoidal endothelium clears small immune complexes
DOI : 10.4049/jimmunol.1202017

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381350

S. Burnett, Conditional macrophage ablation in transgenic mice expressing a Fas-based suicide gene, Journal of Leukocyte Biology, vol.75, issue.4, pp.612-623, 2004.
DOI : 10.1189/jlb.0903442

K. Macdonald, An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammation, Blood, vol.116, issue.19, pp.3955-3963, 2010.
DOI : 10.1182/blood-2010-02-266296

A. Harris, C. Pinkert, M. Crawford, W. Langdon, R. Brinster et al., The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells, Journal of Experimental Medicine, vol.167, issue.2, pp.353-371, 1988.
DOI : 10.1084/jem.167.2.353

Q. Gong, Importance of Cellular Microenvironment and Circulatory Dynamics in B Cell Immunotherapy, The Journal of Immunology, vol.174, issue.2, pp.817-826, 2005.
DOI : 10.4049/jimmunol.174.2.817

E. Nemeth, A. Baird, O. Farrelly, and C. , Microanatomy of the liver immune system, Seminars in Immunopathology, vol.160, issue.6, pp.333-343, 2009.
DOI : 10.1007/s00281-009-0173-4

G. Van-der-bij, Experimentally induced liver metastases from colorectal cancer can be prevented by mononuclear phagocyte-mediated monoclonal antibody therapy, Journal of Hepatology, vol.53, issue.4, pp.677-685, 2010.
DOI : 10.1016/j.jhep.2010.04.023

S. De-haij, In vivo Cytotoxicity of Type I CD20 Antibodies Critically Depends on Fc Receptor ITAM Signaling, Cancer Research, vol.70, issue.8, pp.3209-3217, 2010.
DOI : 10.1158/0008-5472.CAN-09-4109

M. Chao, Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma, Cell, vol.142, issue.5, pp.699-713, 2010.
DOI : 10.1016/j.cell.2010.07.044

E. Mossner, Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity, Blood, vol.115, issue.22, pp.4393-4402, 2010.
DOI : 10.1182/blood-2009-06-225979

M. Glennie, R. French, M. Cragg, and R. Taylor, Mechanisms of killing by anti-CD20 monoclonal antibodies, Molecular Immunology, vol.44, issue.16, pp.3823-3837, 2007.
DOI : 10.1016/j.molimm.2007.06.151

H. Luche, O. Weber, N. Rao, T. Blum, C. Fehling et al., Faithful activation of an extra-bright red fluorescent protein in ???knock-in??? Cre-reporter mice ideally suited for lineage tracing studies, European Journal of Immunology, vol.312, issue.1, pp.43-53, 2007.
DOI : 10.1002/eji.200636745

R. Rickert, J. Roes, and K. Rajewsky, B lymphocyte-specific, Cre-mediated mutagenesis in mice, Nucleic Acids Research, vol.25, issue.6, pp.1317-1318, 1997.
DOI : 10.1093/nar/25.6.1317

URL : http://doi.org/10.1093/nar/25.6.1317

N. Van-rooijen and A. Sanders, Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications, Journal of Immunological Methods, vol.174, issue.1-2, pp.83-93, 1994.
DOI : 10.1016/0022-1759(94)90012-4

S. Celli, F. Lemaitre, and P. Bousso, Real-Time Manipulation of T Cell-Dendritic Cell Interactions In Vivo Reveals the Importance of Prolonged Contacts for CD4+ T Cell Activation, Immunity, vol.27, issue.4, pp.625-634, 2007.
DOI : 10.1016/j.immuni.2007.08.018